Cryo-Cell International, Inc. CCEL
AMEX
| 08/31/2026 | 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 69.54% | 55.87% | -83.35% | -105.06% | -28.74% |
| Total Depreciation and Amortization | -5.71% | -0.23% | 0.59% | -2.71% | 6.35% |
| Total Amortization of Deferred Charges | -1.92% | -1.92% | -1.92% | -1.89% | -1.89% |
| Total Other Non-Cash Items | -36.08% | -44.22% | 2.05% | 1,009.77% | 6,960.64% |
| Change in Net Operating Assets | -212.24% | 212.18% | -29.49% | -17.56% | -25.88% |
| Cash from Operations | -54.99% | 161.09% | -31.68% | -40.62% | 4.08% |
| Capital Expenditure | -162.63% | 47.60% | -8.05% | -709.64% | 79.11% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -106.90% | 104.35% | 138.24% | 79.92% | 338.26% |
| Cash from Investing | -116.37% | 102.33% | 106.64% | 74.04% | 265.96% |
| Total Debt Issued | -- | -100.00% | -57.14% | -0.99% | -- |
| Total Debt Repaid | 98.76% | 17.28% | -8.77% | -290.24% | -70.40% |
| Issuance of Common Stock | -100.00% | -- | -- | -100.00% | 2,210.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -393.29% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | 100.00% | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 98.78% | -328.57% | 26.29% | -38.29% | -71.94% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 619.19% | 400.93% | 79.46% | -85.20% | 146.98% |